Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Tuberculosis (TB) is still a major challenge for global health, but in recent years there have been several important developments in treatment options. Shorter treatment regimens for latent TB, based on conventional drugs, offer better adherence and fewer side effects, while new and repurposed antibiotics have opened the door to more effective, shorter and less side effect-heavy treatments for drug susceptible TB and multidrug-resistant/extensively drug resistant TB as well as atypical mycobacterioses. This review investigates how these shorter and predominantly oral treatments, in the future, are expected to be used in combination with individualized precision medicine.


Christian Kraef, Troels Lillebæk, Åse Bengård Andersen, Ole Kirk. New and rediscovered treatments for tuberculosis]. Ugeskrift for laeger. 2022 Mar 07;184(10)

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 35315752

View Full Text